Primum non nocere: Antithombotics after intracerebral hemorrhage?

Neurology

Volumn 66, Issue 2, 2006, Pages 162-163

  Goldstein, Larry B ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

ANTICOAGULANT THERAPY; BRAIN HEMORRHAGE; CEREBROVASCULAR DISEASE; EDITORIAL; EMBOLISM; HEART ATRIUM FIBRILLATION; HEART VALVE; HIGH RISK POPULATION; HUMAN; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; THROMBOCYTE AGGREGATION; UNSPECIFIED SIDE EFFECT; VASCULAR AMYLOIDOSIS; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; MEDICAL RECORD; NOTE; RECURRENT DISEASE;

CARDIOVASCULAR DISEASES; CEREBRAL HEMORRHAGE; CEREBROVASCULAR DISORDERS; FIBRINOLYTIC AGENTS; HUMANS; MEDICAL RECORDS; RECURRENCE;

EID: 33644922701     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000196237.84921.fb     Document Type: Editorial

References (11)

1. Viswanathan A, Rakich SM, Engel C, et al. Antiplatelet use after intracerebral hemorrhage. Neurology 2006;66:206-209.
2. Wijdicks EFM, Schievink WI, Brown RD, Mullany CJ. The dilemma of discontinuation of anticoagulation therapy for patients with intracranial hemorrhage and mechanical heart valves. Neurosurgery 1998;42:769-773.
3. Phan TG, Koh M, Wijdicks EFM. Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk. Arch Neurol 2000;57:1710-1713.
4. Pessin MS, Estol CJ, Lafranchise F, Caplan LR. Safety of anticoagulation after hemorrhagic infarction. Neurology 1993;43:1298-1303.
5. Leker RR, Abramsky O. Early anticoagulation in patients with prosthetic heart valves and intracerebral hematoma. Neurology 1998;50:1489-1491.
6. Eckman MH, Rosand J, Knudsen KA, Singer DE, Greenberg SM. Can patients be anticoagulated following lobar hemorrhage? A decision analysis. Stroke 2003;34:1710-1716.
7. Hayden M, Pigone M, Phillips C, Mulrow C. Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002;136:161-172.
8. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for the prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 2002;324:71-86.
9. He J, Whelton PK, Vu B, Klag MJ. Aspirin and risk of hemorrhagic stroke. JAMA 1998;280:1930-1935.
10. Wong KS, Chan YL, Liu JY, Gao S, Lam WW. Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages. Neurology 2003;60:511-513.
11. Wong KS, Mok V, Lam WW, Kay R, Tang A, Chan YL, Woo J. Aspirin-associated intracerebral hemorrhage: clinical and radiologic features. Neurology 2000;54:2298-2301.